Insulin Resistance and the HOMA-IR Number Nobody Explains

HOMA-IR, or homeostatic model assessment of insulin resistance, is calculated from just two values, fasting glucose and fasting insulin, using a simple formula to estimate how resistant your cells have become to insulin's effects. Because it requires only a standard blood draw rather than the more involved clamp studies researchers use in metabolic labs, HOMA-IR has become a widely used proxy for insulin resistance in both research and increasingly in clinical practice.

Insulin resistance can develop years, sometimes over a decade, before fasting glucose rises enough to meet the threshold for prediabetes or type 2 diabetes, largely because the pancreas compensates by producing more insulin to maintain normal glucose levels for a long time before that compensation eventually fails. This means a standard fasting glucose test alone can miss significant underlying insulin resistance that a HOMA-IR calculation, which also accounts for insulin levels, would catch earlier.

Why this matters for tracking: because insulin resistance typically develops well before fasting glucose becomes abnormal, HOMA-IR can flag metabolic dysfunction years earlier than a standard glucose test alone would.